SIGACHI 2025-04-01 2025-06-30 SIGACHI 2025-06-30 SIGACHI 2025-04-01 2025-06-30 in-capmkt:OtherExpenses1Member SIGACHI 2025-04-01 2025-06-30 in-capmkt:OtherExpenses2Member SIGACHI 2025-04-01 2025-06-30 in-capmkt:OtherExpenses3Member SIGACHI 2025-04-01 2025-06-30 in-capmkt:OtherExpenses4Member SIGACHI 2025-04-01 2025-06-30 in-capmkt:OtherExpenses5Member SIGACHI 2025-04-01 2025-06-30 in-capmkt:OtherExpenses6Member SIGACHI 2025-04-01 2025-06-30 in-capmkt:OtherExpenses7Member SIGACHI 2025-04-01 2025-06-30 in-capmkt:OtherExpenses8Member SIGACHI 2025-04-01 2025-06-30 in-capmkt:OtherExpenses9Member SIGACHI 2025-04-01 2025-06-30 in-capmkt:OtherExpenses10Member SIGACHI 2025-04-01 2025-06-30 in-capmkt:ReportableSegments1Member SIGACHI 2025-04-01 2025-06-30 in-capmkt:ReportableSegments2Member SIGACHI 2025-04-01 2025-06-30 in-capmkt:ReportableSegments1Member SIGACHI 2025-04-01 2025-06-30 in-capmkt:ReportableSegments2Member SIGACHI 2025-04-01 2025-06-30 in-capmkt:ReportableSegments1Member SIGACHI 2025-06-30 in-capmkt:ReportableSegments1Member SIGACHI 2025-04-01 2025-06-30 in-capmkt:ReportableSegments2Member SIGACHI 2025-06-30 in-capmkt:ReportableSegments2Member SIGACHI 2025-04-01 2025-06-30 in-capmkt:ReportableSegments1Member SIGACHI 2025-06-30 in-capmkt:ReportableSegments1Member SIGACHI 2025-04-01 2025-06-30 in-capmkt:ReportableSegments2Member SIGACHI 2025-06-30 in-capmkt:ReportableSegments2Member SIGACHI 2025-04-01 2025-06-30 ItemsThatWillNotBeReclassifiedToProfitAndLoss1 iso4217:INR iso4217:INR xbrli:shares 000000 NOTLISTED SIGACHI INE368H01018 SIGACHI LABORATORIES LIMITED Main Board Equity 2025-04-01 2026-03-31 2025-08-14 2025-08-04 INR Lakhs Quarterly First quarter Multi segment 2025-08-14 04:00:00 2025-08-14 06:30:00 Not applicable false false NOT TAKEN ANY LOANS FROM ANY ONE 2025-04-01 2025-06-30 Unaudited Standalone 12776000 2171000 14947000 0 0 0 1051000 0 578000 387000 2016000 12931000 0 12931000 1061000 970000 2031000 0 10900000 0 0 0 0 10900000 17668000 28568000 67531000 10 1.61 1.61 0 0 1.61 1.61 1. The above unaudited Financial results as reviewed and recommended by the Audit Committee are considered and approved by the Board of Directors at their respective meetings held on 14th August, 2025. <BR> <BR> 2.These financial results of the company have been prepared in accordance with the Companies (Indian Accounting Standards) Rules, 2015 (Ind AS) prescribed under section 133 of the Companies Act, 2013 and other recognised accounting practices and policies to the extent applicable. <BR> <BR> 3.These Financial results have been subjected to limited review by the Statutory Auditors'. <BR> <BR> 4.These Financial Results are available on the Stock Exchange website (www.msei.in) and also on the company’s website at (www.slllab.com). MISCELLANEOUS EXPENSES 62000 LISTING FEE 55000 CONVEYANCE EXPENSES 50000 CUSTODY FEE 45000 RENT 42000 INSURANCE 37000 OFFICE MAINTENANCE 24000 FACTORY MAINTENANCE 18000 SHARE TRANSFER FEE 17000 OTHER EXPENSES 37000 Bulk Drugs and Intermediates (Lease Rents) 2500000 Investments 12447000 14947000 0 14947000 Bulk Drugs and Intermediates (Lease Rents) 1868000 Investments 12447000 14315000 0 1384000 12931000 Bulk Drugs and Intermediates (Lease Rents) 90500000 Investments 351890000 442390000 0 442390000 Bulk Drugs and Intermediates (Lease Rents) 20549000 Investments 0 20549000 0 20549000 ITEMS THAT WILL NOT BE RECLASSIFIED TO PROFIT OR LOSS 20616000 20616000 2948000 0 17668000